Rajaram Legal advised Matrix Partners India, while Goodwin Procter advised Razorpay. Razorpay raised approx. INR 1208 crores ($160 million) in its Series E funding round led...
Razorpay’s $160 Million Series E Financing Round
Vascular Biogenics Ltd.’s $28.3 Million Shares Offering
Goodwin Procter LLP advised Vascular Biogenics Ltd. on the deal. Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ: VBLT) announced the closing of its underwritten public offering...
Cado Security Ltd’s $10 Million Series A Funding Round
Goodwin Procter LLP advised Cado Security Ltd on the deal. Cado Security Ltd announced its $10 million Series A funding round. Cado Security provides the first and...
CompoSecure’s Merger With Roman DBDR Tech Acquisition
Goodwin Procter LLP advised Roman DBDR, while Morgan, Lewis & Bockius LLP advised CompoSecure on the deal. Simpson Thacher served as counsel to the placement agents....
LUMICKS Technologies’ $93M Series D Financing
Goodwin Procter LLP and Loyens & Loeff advised Lauxera Capital Partners on the deal, while NautaDutilh assisted LUMICKS Technologies B.V. Lauxera Capital Partners announced their investment...
Lauxera Capital Partners’ Investment in LUMICKS
Goodwin Procter LLP advised Lauxera Capital Partners on the deal. Lauxera Capital Partners announced their investment in LUMICKS as part of a $93 million Series D Financing....
KKR’s Acquisition of Ensono
Goodwin Procter LLP advised Charlesbank Capital Partners on the deal, while Simpson Thacher advised KKR. Charlesbank Capital Partners and its portfolio company Ensono signed a definitive agreement...
Tango Therapeutics’ $353 Million Merger with BCTG Acquisition Corp.
Goodwin Procter LLP advised Tango Therapeutics on the deal while Wilson Sonsini Goodrich & Rosati represented BCTG Acquisition Corp. Tango Therapeutics announced its definitive merger agreement with...
Cerevel Therapeutics’ $125 Million Non-dilutive Financing Transaction for Tavapadon
Goodwin Procter LLP advised Cerevel Therapeutics on the deal. Ropes & Gray represented Bain Capital, while Wyrick Robbins Yates & Ponton LLP acted as legal counsel...
Repertoire Immune Medicines’ $189 Million Series B Financing
Goodwin Procter LLP advised Repertoire Immune Medicines on the deal. Repertoire Immune Medicines announced the completion of its $189 million Series B financing. Joining Flagship Pioneering, Repertoire’s...
Mercer Park Brand Acquisition Corp.’s Business Combination with Glass House
Cassels acted as Canadian counsel for Glass House in the transaction while Goodwin Procter LLP advised Mercer Park Brand Acquisition Corp. On April 8, 2021, Mercer...
EML Payments’ Acquisition of Sentenial Limited
Goodwin Procter LLP advised Sentenial Limited on the deal. EML Payments was represented by Arthur Cox and Herbert Smith Freehills LLP. Sentenial Limited announced its sale to...